Timothy J. Lorber
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Timothy J. Lorber
Timothy J. Lorber is recorded as CFO at Shuttle Pharmaceuticals Holdings, Inc. (SHPH). Shuttle Pharmaceuticals Holdings, Inc. reported in an 8-K filed November 28, 2025 that Timothy J. Lorber resigned as Chief Financial Officer, effective November 21, 2025. Shuttle Pharmaceuticals Holdings, Inc. reported in an 8-K filed June 18, 2024 that Timothy J. Lorber was appointed part-time Chief Financial Officer, effective June 13, 2024. The proxy statement of Shuttle Pharmaceuticals Holdings, Inc. reports total compensation of $273,210 for Timothy J. Lorber in fiscal 2025, including a base salary of $222,055. Disclosed compensation is on record for 3 fiscal years.
“On November 21, 2025, Timothy Lorber resigned as Chief Financial Officer of Shuttle Pharmaceuticals Holdings, Inc. (the "Company"), effective immediately.”
“On June 13, 2024, Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation (the "Company"), entered into an employment agreement (the "Employment Agreement") with Mr. Timothy J. Lorber, CPA, 65, pursuant to which Mr. Lorber will serve as the Company's part-time Chief Financial Officer until September 9, 2024 (the "Transition Period") and, effective September 10, 2024, Mr. Lorber will assume the role of full-time Chief Financial Officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-06-13–present
-
2024-06-13–2025-11-21
-
Start not stated–2025-11-21
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Shuttle Pharmaceuticals Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- Anatoly Dritschilo M.D CEO
- Christopher Cooper CEO, CFO
- Ryan Trasolini CEO
- George Scorsis Chairman, Board Member
- Michael Vander Hoek CFO
- Timothy Lorber CFO
- Anatoly Dritschilo CTO
- Adam Chambers Board Member
- Angel Liriano Board Member
- Bette Jacobs Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | former CFO | $222,055 | $273,210 |
| 2024 | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | CFO\ \ | $97,641 | $197,641 |
| 2023 | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | CFO\ \ | — | — |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.